Reliq Health Technologies Inc V.RHT.H

RHT CEO DISCUSS UPDATES FOR 2022

[Humanist]

CEO’s of TDOC, RQHTF, CHPT, and XTMIF Discuss New Trends and Market Opportunities in Electric Vehicles, TeleHealth, and Fintech
 
by @nasdaq on 3 Feb 2022, 07:26
    
NEW YORK, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from CEO’s of: ChargePoint Holdings (NYSE: CHPT), Reliq Health Technologies (OTC: RQHTF) (TSX.V: RHT), Teladoc Health (NYSE: TDOC) and XTM, Inc. (OTC: XTMIF) (CSE: PAID).

Today’s emerging megatrends and technologies are creating trillion dollar opportunities for disruptive innovation in how we live, work and play. Wall Street Reporter highlights the latest comments from industry thought leaders shaping our world today, and in the decades ahead:
Reliq Health Technologies (OTC: RQHTF) (TSX.V: RHT) CEO Lisa Crossley: “Reliq Telehealth Platform Set for Explosive Revenue Growth in 2022”

Reliq Health Technologies (OTC:RQHTF) is now at an inflection point for explosive revenue growth and profitability shared CEO Lisa Crossley during a recent presentation at Wall Street Reporter’s NEXT SUPER STOCK livestream. RQHTF’s iUGO telehealth remote patient monitoring platform has gained significant traction
over the past 12 months, and now has 200,000 patients under contract to be onboarded over the next 18-24 months - which represents over $120 Million in recurring annual revenue at full deployment.

Watch Reliq Health Tech (OTC:RQHTF) (TSX.V:RHT) NEXT SUPER STOCK Video: https://www.wallstreetreporter.com/2022/02/02/next-super-stock-reliq-health-tech-otc-rqhtf-tsx-rht-set-for-explosive-revenue-growth-22-with-new-contracts-1-27-22-livestream/

RQHTF has just turned the corner to profitability and with a current run-rate of $24 million, and expected to double in 2022 as more contracted patients are onboarded.

Lisa added that RQHTF is now starting to throw off significant cash flow, enabling the company to fund growth internally, without the need for capital raises in the near future. A NASDAQ uplisting is expected in 2022, allowing RQHTF valuation to better align with it’s peers in the telehealth and healthtech space.

Lisa explained how new patient contract growth is now “snowballing” - powered by expanded medicare and medicaid coverage and reimbursement amounts for virtual care services like RQHTF provides. RQHTF’s powerful iUGO telemedicine platform supports care coordination and community-based virtual healthcare, allows complex patients to receive high quality care at home, improving health outcomes, and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits.

Watch Reliq Health Tech (OTC:RQHTF) (TSX.V:RHT) NEXT SUPER STOCK Video: https://www.wallstreetreporter.com/2022/02/02/next-super-stock-reliq-health-tech-otc-rqhtf-tsx-rht-set-for-explosive-revenue-growth-22-with-new-contracts-1-27-22-livestream/
For the rest of the article,
https://ceo.ca/@nasdaq/ceos-of-tdoc-rqhtf-chpt-and-xtmif-discuss-new-trends